Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Exenatide Therapy in Hyperglycemic Patients Admitted to the Coronary Intensive Care Unit

NCT00736229 is registered in ClinicalTrials.gov with Saint Luke's Health System as lead sponsor.

NCT NCT00736229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Exenatide Therapy in Hyperglycemic Patients Admitted to the Coronary Intensive Care Unit
Lead sponsor
Saint Luke's Health System
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2008
Completion date
August 31, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, hyperglycemia, myocardial infarction